跳至主要内容
临床试验/CTRI/2020/07/026593
CTRI/2020/07/026593已完成3 期

Pharmaco-therapeutic evaluation of Nagaphani( Opuntia elatior Mill.) fruit in Pandu with special reference to its efficacy in Cancer and Chemotherapy associated Anemia

Institute for Post Graduate Teaching and Research in Ayurveda0 个研究点目标入组 25 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Any type of Cancer patients under Chemotherapy associated with Anemia
  • Hb% below 12gm for female and below 13gm for male or reduced RBC count

排除标准

  • Patient who are not under Chemotherapy
  • Pregnancy and Lactation
  • Severe Renal/Hepatic/Cardiac disease
  • Any continuing blood loss
  • Hemoglobin percentage below 6gm

研究者

发起方
Institute for Post Graduate Teaching and Research in Ayurveda

相似试验